NCT00768196View on ClinicalTrials.gov

Prevalence of EED and Quality of Life Evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD Patients

CompletedOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

September 30, 2008

Study Completion Date

February 28, 2009

Conditions
Gastroesophageal Reflux Disease
Trial Locations (4)

Unknown

Research Site, Cheonan

Research Site, Seoul

Research Site, Sungnam

Research Site, Suwon

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT00768196 - Prevalence of EED and Quality of Life Evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD Patients | Biotech Hunter | Biotech Hunter